Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ887888-0,73
KB809,5810,50,19
PKN62,6462,68-0,79
Msft416,1416,5-0,24
Nokia3,21153,2145-0,93
IBM191,18192,05-0,26
Mercedes-Benz Group AG73,7273,730,50
PFE27,7327,750,07
19.03.2024 12:16:39
Indexy online
AD Index online
select
AD Index online
 

  • 05.01.2021 16:18:59
Biofarm Bucurest (ROBIO.BX, Bucharest)
Závěr k 18.3.2024 Změna (%) Změna (RON) Objem obchodů (RON)
0,824 1,86 0,01 35 369
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.03.2024
Popis společnosti
Obecné informace
Název společnostiBiofarm SA
TickerBIO
Kmenové akcie:Ordinary Shares
RICROBIO.BX
ISINROBIOFACNOR9
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 30.09.2023 402
Akcie v oběhu k 31.12.2023 985 367 224
MěnaRON
Kontaktní informace
UliceStr. Logofatul Tautu nr. 99, Sector 3
MěstoBUCURESTI
PSČ031212
ZeměRomania
Kontatní osobaDaniel Constantin
Funkce kontaktní osobyManager of Legal Department and Relationship with Investors
Telefon40 213 010 600
Fax40213010605
Kontatní telefon400 213 010 697

Business Summary: Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Company’s product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Biofarm SA revenues increased 1% to RON280.3M. Net income increased 9% to RON77M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other Operating Income increase from RON327K to RON794K (income). Basic Earnings per Share excluding Extraordinary Items increased from RON0.07 to RON0.08.
Odvětvová klasifikace
TRBC2012Generic Pharmaceuticals
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
SICPharmaceutical Preparations
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 19.03.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
General Manager, Executive DirectorCatalin Vicol4706.12.201815.11.2018
Chief Financial OfficerMihai Zoescu-18.01.202118.01.2021
Chief AccountantMonica Matei-09.05.201609.05.2016
Head of the Shareholding Legal OfficeZoia Ion-01.01.1996
Human Resources ManagerMaria Bogde-02.04.201802.04.2018
Manager of Legal Department and Relationship with InvestorsDaniel Constantin-19.08.2019
Administrative ManagerLucian Bogaciu-01.01.202001.01.2020
Field Force ManagerIorga Danut-21.01.201921.01.2019
Trade ManagerMoise Dragos-21.01.201921.01.2019
Quality ManagerMarcela Gherghescu-15.10.2020